A bill to de-link research and development incentives from drug prices for new medicines to treat HIV/AIDS and to stimulate greater sharing of scientific knowledge.
The bill’s titles are written by its sponsor.
Sponsor and status
Sponsor. Senator for Vermont. Independent.
Last Updated: May 26, 2011
Length: 20 pages
May 26, 2011
112th Congress, 2011–2013
Died in a previous Congress
This bill was introduced on May 26, 2011, in a previous session of Congress, but was not enacted.
May 26, 2011
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.
Mar 20, 2013
Reintroduced Bill — Introduced
This activity took place on a related bill, S. 626 (113th).
S. 1138 (112th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
This bill was introduced in the 112th Congress, which met from Jan 5, 2011 to Jan 3, 2013. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
Civic Impulse. (2018). S. 1138 — 112th Congress: Prize Fund for HIV/AIDS Act. Retrieved from https://www.govtrack.us/congress/bills/112/s1138
“S. 1138 — 112th Congress: Prize Fund for HIV/AIDS Act.” www.GovTrack.us. 2011. March 20, 2018 <https://www.govtrack.us/congress/bills/112/s1138>
|title=S. 1138 (112th)
|accessdate=March 20, 2018
|author=112th Congress (2011)
|date=May 26, 2011
|quote=Prize Fund for HIV/AIDS Act
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.